PMID: 6170959Jan 1, 1980Paper

Pharmacological comparison of bPTH-(1-34) and other hypotensive peptides in the dog

Peptides
T E TennerP K Pang

Abstract

The purpose of the present study was to compare the potency, effectiveness and duration of action of synthetic bPTH-(1-34) with those of other known hypotensive peptides in the anesthetized dog. Of sixteen peptides tested in the present study only 8 were demonstrated to possess hypotensive activity. While bPTh-(1-34) was one of the least potent of the hypotensive peptides, it was equal to or greater than the other peptides in terms of effectiveness and duration of action. Of all the peptides studied, substance P and eledosin were the most potent in terms of their hypotensive action. It is suggested that perhaps substance P and eledoisin might act at a different site or through different mechanisms than do vasoactive intestinal peptide (V.I.P.), corticotropin inhibiting peptide (C.I.P.), neurotensin, xenopsin, bradykinin and bPTH-(1-34).

References

Sep 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·C H LiC Y Lee
Jul 1, 1978·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·K KawanishiT Ofuji
Oct 15, 1977·European Journal of Pharmacology·R W Bury, M L Mashford
Dec 1, 1976·Acta Physiologica Scandinavica·S RosellK Folkers
Jun 1, 1968·European Journal of Pharmacology·G A Charbon
Jan 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·P K PangH F Janssen
May 1, 1980·General and Comparative Endocrinology·P K PangJ A Yee
Jul 15, 1962·Experientia·W HAEFELY, A HUERLIMANN

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.